To main content

Neuropsychological evaluation and rehabilitation in multiple sclerosis (NEuRoMS): A mixed-methods, multi-centre feasibility randomised controlled trial

Abstract

Background Cognitive difficulties are common in people with multiple sclerosis (pwMS), yet access to neuropsychological rehabilitation is often limited or only provided to those with more severe impairments. The NEuRoMS intervention provides brief, tailored neuropsychological rehabilitation for pwMS with mild-to-moderate cognitive difficulties. Objectives To evaluate feasibility and acceptability of the intervention and test procedures for a definitive trial. Methods A mixed-methods, multi-centre feasibility randomised controlled trial (RCT) was conducted. Feasibility outcomes were recruitment, retention, outcome completion, randomisation, intervention delivery and fidelity. Quantitative data were collected at baseline, 3- and 6-months, supplemented by interviews with pwMS and healthcare providers. Results Seventy-nine participants were randomised (mean age = 54.5 (SD = 11.5); 70% women) from three UK MS clinics. Most feasibility criteria were met: retention (>80%) and outcome-measure completion (81%–89%) were high, and trial procedures were acceptable. Intervention delivery was feasible and delivered as intended, but staffing-related recruitment challenges need addressing in future trials. Preliminary signal of efficacy was observed, with 3.42-point difference (effect size = 0.48) in the planned primary outcome (MS psychological impact) favouring the intervention, supported by qualitative evidence of sustained behaviour change. Conclusion The NEuRoMS intervention and trial procedures were feasible and acceptable, with early indication of efficacy. A definitive RCT is underway.
Read the publication

Category

Academic article

Language

English

Author(s)

  • Roshan das Nair
  • Gogem Topcu
  • Nia Goulden
  • Shaun Harris
  • Jacqueline R. Mhizha-Murira
  • Haley Morris
  • Polly Swain
  • Lauren A. Taylor
  • Jonathan Hancock
  • Laura Price
  • Jenna Hill
  • Avril Drummond
  • Zoë Hoare
  • Deborah Fitzsimmons
  • Denise Kendrick
  • Stephen Timmons
  • Shirley Thomas
  • Jennifer Martin
  • Rod Middleton
  • James C. Turton
  • Clare Bale
  • Andrea Stennett
  • Rachel Simkiss
  • Kimberley Fletcher
  • Emma C. Tallantyre
  • Klaus Schmierer
  • Nikos Evangelou
  • On behalf of the NEuRoMS Collective

Affiliation

  • SINTEF Digital / Health Research
  • United Kingdom
  • Cardiff University
  • Loughborough University
  • Staffordshire University
  • University of Birmingham
  • University of London
  • University of Nottingham
  • Bangor University
  • Swansea University
  • Nottingham University Hospital
  • Royal London Hospital
  • St. Olavs Hospital, Trondheim University Hospital

Date

24.09.2026

Year

2026

Published in

Multiple Sclerosis Journal, Experimental, Translational and Clinical

Volume

12

Issue

3

View this publication at Norwegian Research Information Repository